Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 3 Part 1 1.: Difference between revisions

From GxPlex

Jump to: navigation, search
← Older edit
gxplex>GxPlexBot
Import from GxPlex Excel
m 1 revision imported
Β 
(4 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{#set:
{{ReferenceData
|HasDocument=Document:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
|has_document=Document:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
|RefScope=HM
|module=2
|RefDocPart=Schedule 3
|unit=2.3.3
|scope=HM
|doc_part=Schedule 3
Part 1
Part 1
1.
1.
|RefLanguage=EN
|language=EN
|RefTagsEN=
|entry_by=Florian Adragna
|RefTagsOriginal=
|contributors=
|RefTagsFR=
|tags=TAG-00134-Eth-kom ++ TAG-00135-Inv-ntr ++ TAG-00059-Reg-lat
}}
|tags_display=[[Glossary:TAG-00134-Eth-kom|Ethics committee]], [[Glossary:TAG-00135-Inv-ntr|Trial site]], [[Glossary:TAG-00059-Reg-lat|Regulatory submission]]
Β 
|comment=Information required for ethics committee opinion application
{{:Document:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004}}
|content=APPLICATION FOR ETHICS COMMITTEE OPINION
Β 
{| class="wikitable gplx-infobox"
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Scope
| HM
|-
! Document part
| Schedule 3
Part 1
1.
|-
! Language
| EN
|-
! Original entry by
| Florian Adragna
|-
! Contributors
|
|-
! Tags (EN)
|
|-
! Tags (original language)
|
|-
! Tags (FR)
| Β 
|-
! Comment
| Information required for ethics committee opinion application
|}
Β 
== Content ==
APPLICATION FOR ETHICS COMMITTEE OPINION
1.Β  An application document including the following information or, in each case, an explanation of why that information is not being providedβ€”
1.Β  An application document including the following information or, in each case, an explanation of why that information is not being providedβ€”
[…]
[…]
(t)details of any proposed trial site and its suitability for conducting the trial.
(t)details of any proposed trial site and its suitability for conducting the trial.
}}

Latest revision as of 13:49, 16 July 2026



Document information
Reference GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
Validity area GBR
Scope(s) HM
Document name The Medicines for Human Use (Clinical Trials) Regulations 2004
Version / Revision 01-May-2004
Status Current
Document type Legal act
Language(s) EN
Description The Medicines for Human Use (Clinical Trials) Regulations 2004
Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 2 β€” Unit 2.3.3
Scope HM
Document part Schedule 3

Part 1 1.

Language EN
Original entry by Florian Adragna
Contributors
Tags Ethics committee, Trial site, Regulatory submission

Content

APPLICATION FOR ETHICS COMMITTEE OPINION 1. An application document including the following information or, in each case, an explanation of why that information is not being providedβ€” […] (t)details of any proposed trial site and its suitability for conducting the trial.

Retrieved from "https://gxplex.org/index.php?title=Reference:GBR_The_Medicines_for_Human_Use_(Clinical_Trials)_Regulations_2004_01-May-2004_Schedule_3_Part_1_1.&oldid=18033"